In the BioHarmony Drug Report Database

"Preview" Icon

Atovaquone

Mepron (atovaquone) is a small molecule pharmaceutical. Atovaquone was first approved as Mepron on 1992-11-25. It is used to treat cerebral toxoplasmosis, malaria, and pneumocystis pneumonia in the USA. It is known to target Cytochrome b.

 

Trade Name

 

Mepron
 

Common Name

 

atovaquone
 

ChEMBL ID

 

CHEMBL1450
 

Indication

 

cerebral toxoplasmosis, malaria, pneumocystis pneumonia
 

Drug Class

 

Image (chem structure or protein)

Atovaquone structure rendering